| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10965383 | Vaccine | 2014 | 7 Pages |
Abstract
Ninety-five percent of a large cohort of uninfected infants born to HBsAg-positive mothers in the United States responded to primary HepB vaccine series. The proportion of infants with anti-HBs <10Â mIU/mL increased with longer interval between the final vaccine dose and PVST. Optimal timing of PVST is within 1-2 months of final vaccine dose to avoid unnecessary revaccination.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Stephen C. Ko, Sarah F. Schillie, Tanja Walker, Steven L. Veselsky, Noele P. Nelson, Julie Lazaroff, Susan Crowley, Cristina Dusek, Khalilah Loggins, Kenneth Onye, Nancy Fenlon, Trudy V. Murphy,